JP2008542205A5 - - Google Patents

Download PDF

Info

Publication number
JP2008542205A5
JP2008542205A5 JP2008510309A JP2008510309A JP2008542205A5 JP 2008542205 A5 JP2008542205 A5 JP 2008542205A5 JP 2008510309 A JP2008510309 A JP 2008510309A JP 2008510309 A JP2008510309 A JP 2008510309A JP 2008542205 A5 JP2008542205 A5 JP 2008542205A5
Authority
JP
Japan
Prior art keywords
group
ether group
ether
compound represented
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008510309A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008542205A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/017706 external-priority patent/WO2006122020A2/en
Publication of JP2008542205A publication Critical patent/JP2008542205A/ja
Publication of JP2008542205A5 publication Critical patent/JP2008542205A5/ja
Pending legal-status Critical Current

Links

JP2008510309A 2005-05-06 2006-05-08 4−ビフェニリルアゼチジン−2−オンの製造方法 Pending JP2008542205A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67833605P 2005-05-06 2005-05-06
US72692905P 2005-10-14 2005-10-14
PCT/US2006/017706 WO2006122020A2 (en) 2005-05-06 2006-05-08 Process for production of 4-biphenylyazetidin-2-ones

Publications (2)

Publication Number Publication Date
JP2008542205A JP2008542205A (ja) 2008-11-27
JP2008542205A5 true JP2008542205A5 (cg-RX-API-DMAC10.html) 2009-07-30

Family

ID=37101971

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008510309A Pending JP2008542205A (ja) 2005-05-06 2006-05-08 4−ビフェニリルアゼチジン−2−オンの製造方法

Country Status (14)

Country Link
US (1) US20080287663A1 (cg-RX-API-DMAC10.html)
EP (1) EP1893571A2 (cg-RX-API-DMAC10.html)
JP (1) JP2008542205A (cg-RX-API-DMAC10.html)
KR (1) KR20080011687A (cg-RX-API-DMAC10.html)
AU (1) AU2006244212A1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0611045A2 (cg-RX-API-DMAC10.html)
CA (1) CA2607939A1 (cg-RX-API-DMAC10.html)
EA (1) EA200702428A1 (cg-RX-API-DMAC10.html)
IL (1) IL187155A0 (cg-RX-API-DMAC10.html)
MA (1) MA29496B1 (cg-RX-API-DMAC10.html)
MX (1) MX2007013872A (cg-RX-API-DMAC10.html)
NO (1) NO20076161L (cg-RX-API-DMAC10.html)
TW (1) TW200726746A (cg-RX-API-DMAC10.html)
WO (1) WO2006122020A2 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2608108A1 (en) * 2005-05-09 2006-11-16 Microbia, Inc. Organometal benzenephosphonate coupling agents
AU2006244043A1 (en) * 2005-05-11 2006-11-16 Microbia, Inc. Processes for production of phenolic 4-biphenylylazetidin-2-ones
EA200702614A1 (ru) * 2005-05-25 2008-04-28 Майкробиа, Инк. Способы получения 4-(бифенилил)азетидин-2-оналкилфосфиновых кислот
WO2008061238A2 (en) * 2006-11-16 2008-05-22 Ironwood Pharmaceuticals, Inc. Processes for production of 4-biphenylyazetidin-2-ones
CN101993403B (zh) * 2009-08-11 2012-07-11 浙江海正药业股份有限公司 氮杂环丁酮类化合物及医药应用
WO2013152476A1 (en) 2012-04-10 2013-10-17 Theracos, Inc. Process for the preparation of benzylbenzene sglt2 inhibitors

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3794734A (en) 1971-03-03 1974-02-26 Merck & Co Inc Methods of treating edema and hypertension using certain 2-aminoethylphenols
US5561227A (en) * 1991-07-23 1996-10-01 Schering Corporation Process for the stereospecific synthesis of azetidinones
US5688787A (en) * 1991-07-23 1997-11-18 Schering Corporation Substituted β-lactam compounds useful as hypochlesterolemic agents and processes for the preparation thereof
AU658441B2 (en) * 1991-07-23 1995-04-13 Schering Corporation Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
CA2158191A1 (en) * 1994-09-16 1996-03-17 Junji Yokoi Method for preventing settlement of aquatic fouling organisms
US5656624A (en) * 1994-12-21 1997-08-12 Schering Corporation 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents
US5756470A (en) 1996-10-29 1998-05-26 Schering Corporation Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
US6077850A (en) * 1997-04-21 2000-06-20 G.D. Searle & Co. Substituted benzopyran analogs for the treatment of inflammation
US6207822B1 (en) * 1998-12-07 2001-03-27 Schering Corporation Process for the synthesis of azetidinones
CA2353981C (en) * 1998-12-07 2005-04-26 Schering Corporation Process for the synthesis of azetidinones
PH12000002657B1 (en) * 1999-10-12 2006-02-21 Bristol Myers Squibb Co C-aryl glucoside SGLT2 inhibitors
IL156552A0 (en) 2000-12-21 2004-01-04 Aventis Pharma Gmbh Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
IL156550A0 (en) * 2000-12-21 2004-01-04 Aventis Pharma Gmbh Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
TWI291957B (en) * 2001-02-23 2008-01-01 Kotobuki Pharmaceutical Co Ltd Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
BRPI0208384B1 (pt) * 2001-03-28 2016-05-31 Merck Sharp & Dohme síntese enantiosseletiva de compostos intermediários de azetidinona
TWI254635B (en) * 2002-08-05 2006-05-11 Yamanouchi Pharma Co Ltd Azulene derivative and salt thereof
WO2004099132A2 (en) 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Process for the preparation of trans-isomers of diphenylazetidinone derivatives
DE602004008100T2 (de) * 2003-11-10 2008-04-30 Microbia Inc., Cambridge 4-biarylyl-1-phenylazetidin-2-one
AU2006244043A1 (en) * 2005-05-11 2006-11-16 Microbia, Inc. Processes for production of phenolic 4-biphenylylazetidin-2-ones

Similar Documents

Publication Publication Date Title
JP2008540557A5 (cg-RX-API-DMAC10.html)
JP2008545700A5 (cg-RX-API-DMAC10.html)
JP2004536811A5 (cg-RX-API-DMAC10.html)
EP1840125B1 (fr) Intermédiaires pour la production de dioxane-2-alkylcarbamates
JP2011500769A5 (cg-RX-API-DMAC10.html)
JP2007511546A5 (cg-RX-API-DMAC10.html)
JP2018529687A5 (cg-RX-API-DMAC10.html)
JP2003520235A5 (cg-RX-API-DMAC10.html)
JP2010510976A5 (cg-RX-API-DMAC10.html)
CA2472776A1 (en) Process for the manufacture of hmg-coa reductase inhibitors
JP2004083852A5 (cg-RX-API-DMAC10.html)
WO2004087790A3 (de) Gemische von (meth)acrylester von polyalkoxyliertem trimethylolpropan
JP2014210738A (ja) ジベンジルトリチオカーボネート誘導体およびその製造方法
JP2005538200A5 (cg-RX-API-DMAC10.html)
JP2004010877A5 (cg-RX-API-DMAC10.html)
CN1037899A (zh) 制备3,3-二苯基丙烯酰胺类的改进方法
RU2007104036A (ru) Способ получения диизопропил (гидроксиметил)-циклопропил)окси) метилфосфоната
JP6262972B2 (ja) 化合物、及びその製造方法、並びにボリコナゾールの製造方法
US7335785B2 (en) Acetylene alcohols having a fluoroalkyl group and methods for preparing the same
JP2010510185A5 (cg-RX-API-DMAC10.html)
JP2007513070A5 (cg-RX-API-DMAC10.html)
JP4651969B2 (ja) エポキシトリアゾール化合物の製造方法
JP2007503406A5 (cg-RX-API-DMAC10.html)
Kvíčala et al. Preparation of intermediates for fluorinated lignans by conjugated and tandem additions on 3-fluorofuran-2 (5H)-one
JP2010159358A5 (cg-RX-API-DMAC10.html)